Health Care/Hospital

Beijing 101 Launches Tri-Action Scalp Revival Treatment, The Ultimate Multi-Technology Scalp Rejuvenation Solution

SINGAPORE, Dec. 10, 2025 /PRNewswire/ -- Beijing 101 Hair Consultants is thrilled to announce the launch of its latest treatment innovation – the  Tri-Action Scalp Revival Treatment – a systematic, multi-technology hair and scalp treatment that cleanses, nourishes, and rejuvenates the scalp throug...

2025-12-10 10:00 1352

MALAYSIA UNVEILS FIRST FLAGSHIP MEDICAL TOURISM HOSPITAL AWARD WINNER TO DRIVE GLOBAL ECONOMY COMPETITIVENESS

KUALA LUMPUR, Malaysia, Dec. 10, 2025 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) marked a major milestone in its medical tourism journey today with the announcement of the Winner of the Flagship Medical Tourism Hospital (FMTH) Programme, an initiative initiated and led by the Malay...

2025-12-10 09:40 1812

D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical Programs

SHANGHAI, Dec. 10, 2025 /PRNewswire/ -- D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a$108 million Series B financing round. The funding round was backed by a distinguished group ...

2025-12-10 09:30 2327

Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody

SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ...

2025-12-10 08:26 1983

Lee's Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights

* Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential * Synergistic and complementary to Lee's Pharm's existing products pipeline, and * Acquisition of rights as licensor and manufacturer of Staccato® alprazolam under a global ...

2025-12-10 08:00 2845

PhyxUp Health Leads Innovation in US Rehabilitation Market with AI-Powered Remote Therapeutic Monitoring(RTM), Launches $1M Seed Funding Round

SAN FRANCISCO, Dec. 9, 2025 /PRNewswire/ -- PhyxUp Health , an AI-driven Remote Therapeutic Monitoring (RTM) platform founded by a former physical therapist andHarvard graduate, is transforming how rehabilitation clinics operate throughoutthe United States. Built as a ...

2025-12-10 00:00 1707

BestQool Launches Christmas Campaign Crossing Into 2026 Before the Next Wave of New Product Updates

NEW YORK, Dec. 9, 2025 /PRNewswire/ -- BestQool is now giving a holiday offer to help people smoothly move into 2026 as the year comes to an end and the holidays approach. FromDecember 10, 2025, to January ...

2025-12-09 23:56 1644

Neurophet Introduced Use Cases of Its AI-based Brain Imaging Analysis Solutions at the SEACURE Symposium Hosted by Nanyang Technological University in Singapore

* Introduced brain-imaging analysis products, including Neurophet AQUA AD, which enables monitoring of adverse effects related to Alzheimer's disease treatments * Highlighted clinical value of Neurophet AQUA AD…To accelerate efforts across healthcare institutions inSoutheast Asia SEOUL, South...

2025-12-09 22:00 1836

Medit Launches AuraVue: A Unified 3D Intraoral Scan and X-Ray Visualization Powered by Overjet AI

NEWPORT BEACH, Calif., Dec. 9, 2025 /PRNewswire/ -- Medit, a global leader in 3D intraoral scanning and digital dentistry solutions, today announced the launch of AuraVue, a next-generation visualization and consultation platform that integrates Overjet's AI technology to deliver real-time diagno...

2025-12-09 21:30 1268

AI CAD-OCI Integration Underway: ALL CONEC Begins Validation of Digital Prosthetic Data Workflow

SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- ALL CONEC has been chosen as a participant in the Dream Venture Star 11 Oracle × Uclick Program and will begin validating a unified data workflow for digital prosthetic production. The initiative focuses on integrating design, fabrication, and insp...

2025-12-09 19:55 1146

Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement

SHANGHAI, Dec. 9, 2025 /PRNewswire/ -- Fosun Pharma (SSE: 600196; HKEX: 02196) today announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Limited. ("Yao Pharma"), Shanghai Fosun Pharmaceutical Industrial Development Company Limited, and Pfizer Inc. (NYSE: PFE) have entered into ...

2025-12-09 19:55 1231

Dimora Medical Recognized as Key Driver in Winner Medical's Amazon Award

NEW YORK, Dec. 9, 2025 /PRNewswire/ -- Winner Medical, the parent company of Dimora Medical, has been honored with the Paid Service Operation Excellence Award at the 2025 Amazon Global Selling Seller Conference, which focuses on excellence, innovation and global market. As one of Winner Medical's...

2025-12-09 18:35 1260

ISLAND HOSPITAL NAMED MALAYSIA'S FIRST FLAGSHIP MEDICAL TOURISM HOSPITAL

GEORGETOWN, Malaysia, Dec. 9, 2025 /PRNewswire/ -- Island Hospital is the winner ofMalaysia's first Flagship Medical Tourism Hospital (FMTH) programme, a recognition of its consistent standards in care, safety and patient experience for international patients.

2025-12-09 18:18 1697

Seven Zonta Clubs in Hong Kong unite to promote "Zonta Says NO to Violence Against Women" campaign and to support the Po Leung Kuk's mobile art exhibition "Violence? Love!!: A Voyage of Discovery"

HONG KONG, Dec. 9, 2025 /PRNewswire/ -- The recent tragic fire at Tai Po has brought sadness and loss to our community. The seven Zonta Clubs inHong Kong would like to express our deepest condolences to the victims and to extend our sympathy to all those affected. The swift response from all sect...

2025-12-09 18:05 1251

Dizal Showcases its Strong Hematology Pipeline with New Data from Golidocitinib and Birelentinib at ASH 2025

SHANGHAI, Dec. 9, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for cancer and immunological diseases, announced new data from its hematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting. Highlights includ...

2025-12-09 18:00 1098

VSure and HEYDOC Health Introduce CareConnect Suite, Transforming SME Protection and Digital Healthcare in Malaysia

KUALA LUMPUR, Malaysia, Dec. 9, 2025 /PRNewswire/ -- In a move that reflects the shifting expectations ofMalaysia's modern workforce, VSure Group and virtual healthcare provider HEYDOC Health have jointly launchedCareConnect Suite , a new digital ecosystem aimed at closing long-standing gaps in em...

2025-12-09 15:58 1289

Sweden Recommends: A Dose of Northern Lights Therapy

STOCKHOLM, Dec. 9, 2025 /PRNewswire/ -- As the world's first country to be prescribed for its health benefits,Sweden is now shining a light on one of its most awe-inducing wellness experiences. Aurora Borealis – the original arctic light therapy...

2025-12-09 15:53 993

Phase II Data of Cadonilimab Regimen as Neoadjuvant Therapy for Resectable Gastric Cancer Presented at ESMO Asia 2025

HONG KONG, Dec. 9, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that data from the Phase II study (COMPASSION-25) for its first-in-class PD-1/CTLA-4 bispecific antibody, cadonilimab, in combination with SOX regimen (oxaliplatin + tegafur/gimeracil/oteracil) as n...

2025-12-09 15:50 1806

GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy

YONGIN, South Korea, Dec. 9, 2025 /PRNewswire/ -- GC Genome, a leading clinical genomics and liquid biopsy company, announced that its study analyzing cell-free DNA (cfDNA) fragmentation patterns in 1,154 healthy individuals has been published in Clinical Chemistry (Impact Factor 6.3, 2025). The ...

2025-12-09 14:54 1553

Greenyn Biotechnology Launches Insumate® mcIRBP-19 Bitter Melon Peptide, Targeting the Billion-Dollar Health Supplement Market

TAICHUNG, Dec. 9, 2025 /PRNewswire/ -- Backed by New Medical Association Certification, Insumate® Becomes the Only Bitter Melon Peptide Globally Recognized by FDA-NDI, SNQ, and the Taiwan Complementary Medicine Society (TCMS). As global demand for scientifically validated metabolic health ingred...

2025-12-09 10:30 1385
1 ... 26272829303132 ... 858